RecruitingNCT05001087
A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
A "Physician & Patient-powered" Cohort Registry
Sponsor
Fondazione EMN Italy Onlus
Enrollment
1,900 participants
Start Date
Mar 16, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this observational study is the creation of a national multiple myeloma registry to monitor the current routine clinical practice in Italy and describe the standard of care adopted for the diagnosis and treatment of patients with multiple myeloma in the different Italian hematology centers.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Patients of both sexes
- Age ≥ 18 years
- Diagnosis of active/symptomatic multiple myeloma (according to CRAB and biological parameters) no earlier than 1st January 2019
- Able and willing to sign an informed consent form
Exclusion Criteria1
- None considered
Interventions
OTHERObservation
Not applicable-Observational study
Locations(27)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05001087
Related Trials
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT0725851133 locations
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
NCT0617988873 locations
Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma
NCT068761421 location
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
NCT0698048016 locations
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
NCT0582851132 locations